Ezerx Health Tech

What Ezerx Health Tech does

EzeRx Health Tech Pvt. Ltd. is an India-based MedTech company founded in 2018 and headquartered in Bhubaneswar, Odisha, that manufactures and distributes non-invasive health screening devices. Its flagship product, EzeCheck, is described as India's first IoT-enabled non-invasive hemoglobin meter, which uses optical sensing combined with AI-based signal analysis to deliver hemoglobin readings in under 60 seconds without blood draws, needles, or consumables, claiming 93% accuracy versus CBC and 95%+ sensitivity/specificity as validated by ICMR-RMRC. The portfolio extends to EzeHealth (an AI-enabled school health monitoring solution) and EzeFind (a portable AI-powered smart urine analyzer), with all devices feeding into a cloud-based IoT dashboard featuring GEO tagging for population-level surveillance.

The company makes money primarily through one-time hardware sales of EzeCheck devices (each shipped with 2,500 preloaded test kits, with additional kits sold as consumables) complemented by subscription-style cloud dashboard and analytics services for institutional buyers. Go-to-market is dominated by enterprise field sales targeting large-scale public health initiatives — including Anemia Mukt Bharat, RBSK, Beti Bachao Beti Padhao, POSHAN Abhiyan, and the Swasth Nari Anemia Testing Campaign — alongside CSR/NGO partners (e.g., TATA Steel Foundation, SARU Foundation), hospitals, blood banks, and schools, with a secondary direct-to-consumer e-commerce storefront on its website. The company is CDSCO-certified (Class B), ISO 13485 and IEC 60601-1 compliant, has an FDA 510(k) application in progress, and has scaled to 6,700+ deployed devices and 3.52M+ cumulative screenings across 13+ countries as of March 2025, supported by a strategic investment from Sun Pharmaceutical in late 2023.

Name

Ezerx Health Tech

Legal name

EzeRx Health Tech Pvt. Ltd.

Website

https://ezerx.in

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

51–100 employees

Short description

EzeRx Health Tech is an India-based MedTech company (founded 2018, Bhubaneswar) that manufactures IoT-enabled, non-invasive hemoglobin (EzeCheck) and urine (EzeFind) screening devices, serving government health programs, hospitals, NGOs, and schools across 13+ countries.

Ownership category

akta.pro rank

Product category

Medical Diagnostic Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK)

akta.pro secondary industries

Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI), Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Medical-Grade Device Connectivity & Device Management (MDM) (HLACAFAG)

Keywords

• Non-invasive hemoglobin testing
• Medical diagnostic devices
• Preventive health screening
• IoT health monitoring
• Portable diagnostic equipment

Headquarters

HQ city

Bhubaneswar

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. EzeCheck Device Sales: One-time hardware sales of the EzeCheck non-invasive hemoglobin meter device. Each device comes with 2500 preloaded test kits. Additional test kits can be purchased separately.
2. SaaS/Dashboard Services: Cloud-based data storage and analytics dashboard integration with IoT and GEO tagging capabilities provided as part of the device ecosystem.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

Core offering

EzeRx Health Tech manufactures and sells non-invasive medical diagnostic hardware devices centered on the EzeCheck IoT-enabled hemoglobin meter, which uses optical sensing and AI-based signal analysis to deliver blood-free hemoglobin readings in under 60 seconds. The portfolio also includes EzeFind (portable AI-powered smart urine analyzer) and EzeHealth (AI-enabled school health monitoring solution), all integrated with a cloud-based IoT dashboard with GEO tagging for real-time population-level screening and surveillance.

Product overview

EzeRx Health Tech operates a multi-product MedTech platform built around non-invasive health screening. The core product EzeCheck is India's first IoT-enabled non-invasive hemoglobin meter that delivers pain-free hemoglobin results in under 60 seconds using optical and AI-based technology. It is complemented by EzeFind, a portable AI-powered smart urine analyzer, and EzeHealth, an AI-enabled school health monitoring solution. All devices feed data into a unified cloud-based IoT dashboard with GEO tagging for real-time population health surveillance. The platform serves government programs (Anemia Mukt Bharat, RBSK, POSHAN), hospitals, blood banks, NGOs, CSR partners, and schools for large-scale preventive care.

Differentiator

Problem solved

Functional benefit

Brands

• EzeCheck: India's 1st Non-Invasive Hemoglobin Device - IoT-enabled portable device for pain-free hemoglobin screening in under 60 seconds, clinically validated by ICMR-RMRC.
• EzeHealth
• EzeFind

Products and services

• EzeCheck Non-invasive IoT-enabled hemoglobin meter that uses optical sensing with 10 LED intensity levels and AI-based signal analysis to deliver pain-free hemoglobin readings within 60 seconds. Clinically validated by ICMR-RMRC with 93% accuracy, more than 95% sensitivity and specificity versus CBC tests. Each device ships with 2,500 preloaded test kits. Built for hospitals, government health programs, NGOs, CSR partners, blood banks, and schools.
• EzeHealth AI-enabled school health monitoring solution integrated with the EzeCheck device ecosystem and cloud dashboard. Designed for systematic hemoglobin and basic health screening of students in K-12 schools and colleges, addressing child needle anxiety and feeding population-level health data to education and government stakeholders.
• EzeFind Portable smart urine analyzer powered by AI for point-of-care diagnostic screening. Provides rapid, field-deployable urinalysis to complement the EzeCheck hemoglobin workflow in hospitals, community health camps, and occupational health settings.

Quantifiable outcome

• 93% accuracy within ±1.5 g/dL compared to traditional CBC tests
• +5 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Partnerships

Five partnerships are on record, tiered core and minor.

• ICMR-RMRCcoreStrategic or Co-development PartnerClinical validation partner. ICMR-RMRC (Indian Council of Medical Research - Regional Medical Research Centre) validated EzeCheck's accuracy and clinical reliability. EzeCheck is clinically validated by ICMR-RMRCBB for hemoglobin screening accuracy.
• CDSCOcoreStrategic or Co-development PartnerRegulatory approval certification. EzeCheck is certified by CDSCO (Central Drugs Standard Control Organisation) as a Class B medical device.
• Government Health ProgramscoreStrategic or Co-development PartnerActive partnerships with government health initiatives including Anemia Mukt Bharat, RBSK (Rashtriya Bal Swasthya Karyakram), Beti Bachao Beti Padhao, and POSHAN Abhiyan for mass anemia screening programs.
• Swasth Nari Anemia Testing CampaigncoreStrategic or Co-development PartnerSuccessfully conducted over 2.5 lakh screenings across multiple states under this campaign, partnering with government initiatives for rural anemia screening.
• Clinical/Academic InstitutionsminorStrategic or Co-development PartnerPartnerships with clinical institutions including Himachal Pradesh, Capital Hospital BHU, Maharashtra Medical College, KIMS, Punjab Government, KUES, University of Bonn for research and validation studies.

Scale indicators10 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• HemoCue: Danish-based point-of-care hemoglobin testing company (a Radiometer/Danaher subsidiary) offering the HemoCue Hb 201+ and 301 systems used globally in clinics, blood banks, and anemia screening programs — the most direct incumbent to EzeCheck's hemoglobin franchise.
• Acon Laboratories: US-headquartered manufacturer of point-of-care rapid diagnostic devices including hemoglobin meters and urine analyzers — directly comparable in product category and emerging-market distribution model to EzeRx's device-plus-test-kit approach.
• Sensa Core: India-based manufacturer of point-of-care electrolyte and hemoglobin analyzers sold through hospital and diagnostic-lab channels in India — the closest direct Indian competitor to EzeCheck in hospital and diagnostic-lab procurement.

Broad incumbents

• Masimo: Global non-invasive patient monitoring leader (pulse oximetry, SpHb total hemoglobin) whose rainbow SET platform includes non-invasive hemoglobin (SpHb) measurement in hospital and surgical settings — a powerful well-capitalized competitor if it moves down-market into primary care.
• Nonin Medical: US-based non-invasive pulse oximetry and patient monitoring manufacturer with a portfolio spanning hospital and home-health use cases — comparable in form factor and IoT-enabled monitoring approach to EzeCheck's connected device model.
• Abbott (i-STAT): Abbott's i-STAT and Piccolo point-of-care diagnostics systems deliver lab-quality hemoglobin and chemistry results in clinical settings, representing the established clinical-grade benchmark that EzeCheck must displace in hospital and blood bank accounts.
• Philips Patient Monitoring: Royal Philips offers connected patient monitoring solutions including wearable biosensors and remote monitoring platforms, competing for the same connected-care, multi-parameter hospital and home-health monitoring budgets that EzeRx targets.
• Siemens Healthineers (DCA Vantage / epoc): Siemens Healthineers' DCA Vantage and epoc systems deliver point-of-care HbA1c and blood gas diagnostics used in hospitals and physician offices — a global incumbent with deep hospital channel relationships that EzeRx must compete against for institutional contracts.

Regional players

• Tricog Health: Bengaluru-based digital health startup offering cloud-connected ECG and vital-sign diagnostics for primary care and rural India — directly comparable as an India-focused, IoT-enabled point-of-care diagnostics platform targeting similar government and private healthcare customers.
• SigTuple: Bengaluru-based AI-powered medical diagnostics company (Manthana platform) that applies AI to pathology, retinal, and blood smear analysis — a regional peer applying AI/ML to diagnostic screening across India and emerging markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/EzeRxHealth
• Facebookfacebook.com/ezerxhealth
• LinkedInlinkedin.com/company/ezerxhealth

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ezerx Health Tech